Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Shares Outstanding (Diluted Average) (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $766598.0 as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 39.34% to $766598.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $766598.0 through Dec 2025, up 39.34% year-over-year, with the annual reading at $766598.0 for FY2025, 39.34% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $766598.0 at Spruce Biosciences, up from $589520.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $43.9 million in Q1 2025, with the low at $548344.0 in Q2 2024.
  • Average Shares Outstanding (Diluted Average) over 4 years is $20.7 million, with a median of $23.5 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) surged 72.6% in 2023, then crashed 98.65% in 2024.
  • Over 4 years, Shares Outstanding (Diluted Average) stood at $23.5 million in 2022, then soared by 63.68% to $38.5 million in 2023, then plummeted by 98.57% to $550146.0 in 2024, then skyrocketed by 39.34% to $766598.0 in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $766598.0, $589520.0, and $588653.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.